JUHE:XETRA:XETRA-JPMorgan ETFs (Ireland) ICAV - US Research Enhanced Index Equity UCITS ETF - EUR Hedged (acc) (EUR)

ETF | Others |

Last Closing

USD 49.255

Change

+0.57 (+1.16)%

Market Cap

N/A

Volume

548.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-31 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.09 (+0.16%)

USD 445.28B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.02 (+0.13%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.09 (+0.32%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.04 (+0.12%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.09 (+0.33%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.08 (-0.16%)

USD 104.21B
8R80:XETRA Amundi Index Solutions - Amund..

-0.04 (-0.03%)

USD 98.84B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.11 (+0.20%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+1.06 (+0.99%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+8.32 (+1.35%)

USD 80.38B

ETFs Containing JUHE:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.69% 43% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.69% 43% F 42% F
Trailing 12 Months  
Capital Gain 21.62% 72% C 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.62% 72% C 71% C-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 13.95% 78% C+ 76% C+
Dividend Return 13.95% 77% C+ 74% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.66% 45% F 56% F
Risk Adjusted Return 102.09% 89% A- 91% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.